Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 14/20 | 1.00 |
| ▸ | FYN | P06241 | 9/20 | 1.00 |
| ▸ | MAP2K5 | Q13163 | 5/20 | 1.00 |
| ▸ | LCK | P06239 | 5/20 | 1.00 |
| ▸ | LYN | P07948 | 4/20 | 1.00 |
| ▸ | SRC | P12931 | 4/20 | 1.00 |
| ▸ | FLT3 | P36888 | 4/20 | 1.00 |
| ▸ | PTK6 | Q13882 | 4/20 | 1.00 |
| ▸ | ITK | Q08881 | 4/20 | 1.00 |
| ▸ | HCK | P08631 | 3/20 | 1.00 |
| ▸ | FGR | P09769 | 3/20 | 1.00 |
| ▸ | MAP2K1 | Q02750 | 3/20 | 1.00 |
| ▸ | BRAF | P15056 | 3/20 | 1.00 |
| ▸ | BMX | P51813 | 3/20 | 1.00 |
| ▸ | YES1 | P07947 | 2/20 | 1.00 |
| ▸ | BLK | P51451 | 2/20 | 1.00 |
| ▸ | RET | P07949 | 2/20 | 1.00 |
| ▸ | KIT | P10721 | 2/20 | 1.00 |
| ▸ | MAP2K6 | P52564 | 2/20 | 1.00 |
| ▸ | ERBB4 | Q15303 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22664628 | 1.00 | BTK (1.00) | BTKFYNMAP2K5LCKLYN | |
| SCHEMBL22664612 | 1.00 | BTK (1.00) | BTKFYNMAP2K5LCKLYN | |
| SCHEMBL22664640 | 1.00 | BTK (1.00) | BTKFYNMAP2K5LCKLYN | |
| SCHEMBL22664609 | 1.00 | BTK (1.00) | BTKFYNMAP2K5LCKLYN | |
| SCHEMBL22664616 | 0.92 | MAP2K5 (1.00) | BTKFYNMAP2K5LCKLYN | |
| SCHEMBL22692851 | 0.90 | FYN (1.00) | BTKFYNMAP2K5LCKLYN | |
| SCHEMBL22664653 | 0.89 | MAP2K5 (1.00) | BTKFYNMAP2K5LCKLYN | |
| SCHEMBL22664641 | 0.89 | MAP2K5 (1.00) | BTKFYNMAP2K5LCKLYN | |
| SCHEMBL22664623 | 0.89 | MAP2K5 (1.00) | BTKFYNMAP2K5LCKLYN | |
| SCHEMBL22664618 | 0.89 | MAP2K5 (1.00) | BTKFYNMAP2K5LCKLYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10844038-B2 | 1,2-dithiolane compounds useful in neuroprotection, autoimmune and cancer diseases and conditions | SABILA BIOSCIENCES LLC (US) | 2020-11-24 | — | — | US | claimed |
| US-10844038-B2 | 1,2-dithiolane compounds useful in neuroprotection, autoimmune and cancer diseases and conditions | SABILA BIOSCIENCES LLC (US) | 2020-11-24 | — | — | US | disclosed |
| US-10844038-B2 | 1,2-dithiolane compounds useful in neuroprotection, autoimmune and cancer diseases and conditions | SABILA BIOSCIENCES LLC (US) | 2020-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844038-B2 | 1,2-dithiolane compounds useful in neuroprotection, autoimmune and cancer diseases and conditions | BTK, FYN, YES1 | BTK 1/4885FYN 2/4885MAP2K5 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.